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Abstract
Background  and  objectives:  The  aneurysm  in  the  pulmonary  trunk  is  a  rare  disease.  Because  of
its location,  a  rupture  can  lead  to  right  ventricular  failure  and  sudden  death.  Aneurysmorraphy
is the  most  widely  used  surgical  treatment  in  these  cases.  The  aim  of  this  study  is  to  report  a
successful balanced  general  anesthesia  for  aneurysmorraphy  of  pulmonary  trunk.
Case report:  Male  patient,  28  years,  asymptomatic,  diagnosed  with  an  aneurysm  in  the  pul-
monary trunk.  According  to  the  location  of  the  aneurysm  and  the  consequent  failure  of  the
pulmonary valve,  an  aneurysmorraphy  was  indicated,  with  implantation  of  vascular-valvular
prosthesis  (valved  tube).  We  opted  for  a  balanced  general  anesthesia,  seeking  to  prevent  an
increase in  systemic  and  pulmonary  vascular  resistances,  thus  avoiding  to  cause  stress  on  the
wall of  the  aneurysmal  vessel.
Conclusions:  A  balanced  general  anesthesia,  in  combination  with  adequate  ventilation  to  pre-
vent elevation  in  pulmonary  vascular  pressure,  was  appropriate  for  surgical  repair  of  an
aneurysm  in  the  pulmonary  trunk.
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Anestesia  para  aneurismorraﬁa  de  tronco  de  artéria  pulmonar
Resumo
Justiﬁcativa  e  objetivos:  O  aneurisma  de  tronco  de  artéria  pulmonar  é  uma  doenc¸a  rara.  Por
sua localizac¸ão,  uma  ruptura  pode  conduzir  à  falência  do  ventrículo  direito  e  à  morte  súbita.
A aneurismorraﬁa  é  o  tratamento  cirúrgico  mais  usado  nesses  casos.  O  objetivo  foi  relatar
uma anestesia  geral  balanceada  para  aneurismorraﬁa  de  tronco  de  artéria  pulmonar  feita  com
sucesso.
Relato do  caso:  Paciente  do  sexo  masculino,  28  anos,  assintomático,  diagnosticado  com
aneurisma  de  tronco  de  artéria  pulmonar.  De  acordo  com  a  localizac¸ão  do  aneurisma  e  a  con-
sequente insuﬁciência  da  válvula  pulmonar,  foi  indicada  a  aneurismorraﬁa  com  implante  de
prótese vascular  e  valvular  (tubo  valvado).  Optou-se  pela  anestesia  geral  balanceada,  para
impedir um  aumento  nas  resistências  vasculares  sistêmicas  e  pulmonar  e  evitar-se,  dessa
maneira,  um  estresse  sobre  a  parede  do  vaso  aneurismático.
Conclusões:  A  anestesia  geral  balanceada,  em  associac¸ão  com  uma  ventilac¸ão  adequada  para
evitar elevac¸ão  na  pressão  vascular  pulmonar,  foi  apropriada  para  correc¸ão  cirúrgica  de  um
aneurisma  em  tronco  pulmonar.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um
artigo Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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a  deviation  of  the  QRS  axis  to  the  right  and  a  right  bundle
branch  block.
A Doppler  echocardiography  was  requested,  which
revealed  moderate  dilatation  and  hypertrophy  of  the  right
PAA
RVntroduction
neurysm  is  the  focal  dilatation  of  a  vessel.  Although  it  may
ccur  in  vessels  of  the  venous  system,1 it  is  more  frequent
n  arteries  and  affects  its  three  tunics  (intima,  media,  and
dventitia).  It  is  classiﬁed  as  fusiform,  if  symmetric  and
ilatation  involving  the  entire  circumference,  or  saccular,  if
symmetric  and  only  a  part  of  the  circumference  is  dilated.
Unlike  the  aorta,  which  is  the  most  affected  by
hat  disease,  pulmonary  artery  aneurysm  (PAA)  is  a  rare
ccurrence.2 However,  even  in  a  low  pressure  circuit  as  the
ung,  it  is  subject  to  the  same  hemodynamic  forces  that  pro-
ote  the  growth  of  the  aorta  or  other  arteries  when  affected
y  an  aneurysm.2
The  etiological  causes  of  disease  may  be  idiopathic,
ongenital  heart  defects  (e.g.,  patent  ductus  arteriosus),
asculitis  (autoimmune,  postinfection  or  genetic  factors),
nd  connective  tissue  diseases  such  as  Marfan  syndrome,
mong  others.3,4
Clinically,  it  may  be  manifested  by  dyspnea,  cough,
emoptysis,  and  chest  pain.3 However,  most  patients  with
AA  are  asymptomatic.2,5 The  diagnosis  is  made  at  random
y  routine  screening.
The  presence  of  pain  is  a  symptom  that  indicates  impend-
ng  rupture.  In  this  case,  surgical  treatment  is  recommended
o  prevent  sudden  death  (SD)  caused  by  the  aneurysm  rup-
ure  and  right  ventricle  (RV)  failure.6
Even  when  there  is  no  pain,  but  the  pulmonary  trunk  is
nvolved,  the  risk  of  SD  is  also  high  for  the  same  reasons
ited  above,  and  many  authors  suggest  surgery.7
We  report  a  rare  case  of  anesthesia  for  surgical  treat-
ent  of  pulmonary  trunk  aneurysm  (aneurysmorrhaphy)  in
n  asymptomatic  patient  with  Marfan  syndrome.
The  purpose  of  anesthesia  was  to  keep  under  control
oth  systemic  blood  pressure  (SBP)  and  pulmonary  arterial
ressure  (PAP).
F
a
tTherefore,  we  sought  to  avoid  rupture  of  the  aneurysm,
ts  disastrous  consequences  in  vascular  site,  and  possible
amage  after  surgical  correction.
ase report
ale  patient,  28  years  old,  white,  67  kg,  1.90  m,  diagnosed
ith  a  pulmonary  trunk  aneurysm,  without  other  comorbidi-
ies.
The  patient  had  no  signs  or  symptoms  of  the  disease.  The
iagnosis  was  made  during  a periodic  medical  examination
t  the  company  where  he  worked.
In  the  evaluation  of  the  ﬁrst  tests,  an  increased  heart  size
y  the  growth  of  the  right  ventricle  and  pulmonary  artery
runk  was  noticed  (Fig.  1).  The  electrocardiogram  showedigure  1  Chest  X-ray:  PAA  aneurysm,  increased  RV,  and  devi-
tion  of  the  cardiac  area  to  the  right.  PAA,  pulmonary  artery
runk;  RV,  right  ventricle.
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involved.2,3Figure  2  PAA  aneurysm  and  increased  RV;  PAA,  pulmonary
artery  trunk;  RV,  right  ventricle;  Ao,  aorta;  LV,  left  ventricle.
ventricle,  signiﬁcant  dilation  of  the  pulmonary  artery  trunk
and  its  branches,  and  dysplasia  with  severe  pulmonary  valve
insufﬁciency.  Mean  pulmonary  artery  pressure  was  esti-
mated  at  30  mmHg  (normal  reference  value:  10--18  mmHg).
After  these  tests,  the  patient  was  sent  to  the  hospi-
tal  Beneﬁcência  Portuguesa  (São  Paulo,  Brasil),  where  a
pulmonary  artery  computed  angiography  was  performed.
The  following  relevant  aspects  were  observed:  aneurys-
mal  dilatation  of  the  pulmonary  artery  trunk  measuring
5.8  cm  in  diameter;  pulmonary  valve  annulus  measuring
3.6  cm  ×  3.5  cm  diameter;  medianized  heart  showing  signs
of  right  ventricle  dilatation  and  its  outﬂow.
With  the  diagnosis  of  pulmonary  artery  aneurysm  (Fig.  2)
and  pulmonary  valve  annulus  dilation  (with  impaired  valve),
aneurysmorrhaphy  was  indicated,  with  synthetic  Dacron
tube  and  metal  valve  implantation  in  pulmonary  position
(valved  tube).
On  the  operation  day,  the  patient  was  taken  to  the  oper-
ating  room  and  monitored  with  electrocardioscope,  pulse
oximeter,  and  noninvasive  blood  pressure.  A  large  venous
access  was  placed  in  the  right  upper  limb  and  midazolam
(3  mg)  was  administered  to  provide  anxiolysis/sedation.  At
that  time,  with  normal  values  of  heart  rate  and  blood  pres-
sure,  dexmedetomidine  infusion  was  started  at  a  dose  of
0.5  g  kg−1 h−1 for  15  min,  sufﬁcient  time  to  left  radial  artery
catheterization  in  order  to  invasively  measure  the  pressure.
Induction  of  anesthesia  started  with  preoxygenation
(100%  O2),  reduction  of  dexmedetomidine  to  0.4  g  kg−1 h−1,
c
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entanyl  10  g  kg−1 etomidate  20  mg,  rocuronium
.6  mg  kg−1, and  intravenous  lidocaine  2  mg  kg−1.  After
he  required  time  for  drug  action,  tracheal  intubation  was
erformed  without  complications,  such  as  hypertension  or
achycardia.  Monitoring  was  completed  with  capnography
nd  central  venous  pressure.
The  mechanical  ventilation  was  adjusted  to  FiO2 of  60%,
ith  a  frequency  of  12  breaths  per  minute,  tidal  volume
f  7  mL  kg−1, and  positive  end-expiratory  pressure  (PEEP)  of
 cmH2O,  in  order  to  maintain  EtCO2 between  30--32  mmHg.
Maintenance  of  anesthesia  was  achieved  with  1%  isoﬂu-
ane,  dexmedetomidine  (0.4  g  kg−1 h−1),  and  additional
oses  of  fentanyl  to  complete  20  g  kg−1. Midazolam  and
ocuronium  were  administered  again  during  cardiopul-
onary  bypass  (CPB),  with  another  supplemental  dose  of
uscle  relaxant  at  the  end  of  CPB.
Epsilon-aminocaproic  acid,  an  antiﬁbrinolytic,  was
nfused  at  a  dose  of  100  mg  kg−1 in  the  ﬁrst  hour  of  surgery,
ollowed  by  10  mg  kg−1 h−1 in  order  to  inhibit  ﬁbrinolysis  and
educe  surgical  bleeding.
With  ventilatory  adjustments  described  above,  mainte-
ance  of  blood  gas  values  within  normal  limits,  and  the
sed  drugs,  we  sought  to  prevent  any  event  that  promotes
ncreased  systemic  or  pulmonary  arterial  blood  pressure8
hat  could  increase  the  risk  of  aneurysm  rupture  until  CPB.
CPB  was  performed  with  moderate  hypothermia,  and
neurysmorrhaphy  with  replacement  by  vascular  prosthesis
nd  metallic  prosthetic  valve  was  uneventful.
At  the  end  of  CPB,  the  possible  RV  dysfunction
s  a result  of  the  ischemia  period----reperfusion  on
 dilated/hypertrophic  ventricle----was  prevented  by  the
hoice  of  positive  inotropic  and  vasodilator  milrinone.
The  initial  bolus  of  this  inotropic9 was  suppressed  and  an
nfusion  of  0.5  g  kg−1 min−1 of  the  drug  was  started  still  in
PB.  This  dose  was  continued  until  after  the  end  of  CPB  and
rotamine  administration.  Maintenance  was  then  reduced  to
.3  g  kg−1 min−1 for  another  hour  and,  because  contractile
erformance  was  very  satisfactory,  the  drug  infusion  was
topped.  Discontinuation  of  milrinone  was  made  to  avoid  a
ossible  hypotension  as  a  result  of  this  drug  synergism  with
exmedetomidine.
The  patient  remained  stable  until  the  end  of  surgery  and
as  taken  to  the  ICU  intubated  and  with  continuous  infusion
f  dexmedetomidine.
iscussion
he  tendency  of  any  aneurysm  is  to  continue  gradually
ilating.  Dilation  leads  to  a  stress  on  the  vessel  wall,  a  deter-
ining  factor  for  its  rupture.10 Pulmonary  artery  aneurysm  is
 rare  disease2,7 and  there  is  no  guideline  for  treatment.11-13
Therapy  may  vary  from  conservative7,12 to  surgical2,3
ccording  to  the  aneurysm  location  or  in  the  presence  of
ain  as  a  symptom,  for  example.3 The  invasive  procedures
ange  from  lobectomy  and  embolization  in  more  distal  arter-
es  to  pneumonectomy  when  the  main  pulmonary  artery  isWhen  the  aneurysm  affects  this  artery  trunk,  as  in  the
ase  reported  here,  the  treatment  is  surgical.  At  this  loca-
ion,  there  is  a  risk  that  the  vessel  disruption  leads  to  RV
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ailure  and  sudden  death.  Aneurysmorrhaphy  is  the  most
ommonly  used  surgery  in  such  cases.2
Pulmonary  artery  trunk  aneurysmorrhaphy  is  performed
nder  sternotomy  and  with  cardiopulmonary  bypass  (CPB).
owever,  it  does  not  differ  from  many  of  the  cardiac  surger-
es  routinely  performed.
The  speciﬁc  surgical  time  of  these  types  of  cardiovascular
rocedures  (sternotomy,  pericardiotomy,  aorta  management
nd  cannulation,  among  others)  is  a  potent  stimulus  to  the
ympathetic  nervous  system  and  may  raise  blood  pressure.
s  a  result,  according  to  Laplace’s  law,  an  increased  blood
ressure  (or  increased  vessel  diameter)  exacerbates  the  ten-
ion  on  the  aneurysm  wall  making  it  unstable  and  prone  to
upture.2,14,15
Regarding  pulmonary  artery  aneurysm,  besides  the  con-
ern  with  hypertension,  an  additional  challenge  arises:
reventing  an  increase  in  pulmonary  vascular  resistance
PVR).  An  increased  resistance  in  this  site  would  be  trans-
itted  to  the  pulmonary  trunk,  with  consequent  additional
tress  on  aneurysm  and  increased  RV  afterload.
In  the  case  reported  here,  we  avoid  the  factors  that  could
ontribute  to  increased  PVR,  such  as  hypoxia,  decreased  pH
hypercapnia/respiratory  and  metabolic  acidosis),8 adren-
rgic  and  nociceptive  stimuli.
Tidal  volume  (TV)  and  PEEP  were  reduced  (TV  =  7  mL  kg−1
nd  PEEP  =  3  cm  H2O),  because  these  factors  when  exces-
ive  during  mechanical  ventilation  may  cause  pulmonary
yperdistension  and,  consequently,  increase  in  pulmonary
ascular  resistance.16 Compensation  with  FiO2 (60%)  and
espiratory  rate  (12  bpm)  were  sufﬁcient  for  effective  oxy-
enation  control  and  CO2 elimination.
Regarding  the  anesthetic  technique:  ‘‘almost  any  com-
ination  of  anesthetics  and  vasoactive  drugs  has  favorable
tudies  and  enthusiastic  advocates  who  promote  its  use’’.17
here  is  no  consensus  among  anesthesiologists  about  the
ost  appropriate  technique  for  pulmonary  trunk  aneurys-
orrhaphy.  Here  we  opted  for  balanced  general  anesthesia,
s  this  modality  has  been  routine  in  our  service  for
ardiovascular  surgery  and  results  in  good  hemodynamic
ontrol.
Isoﬂurane,  the  inhaled  agent  chosen,  has  two  desir-
ble  characteristics,  among  others,  for  the  case  reported
ere:  ﬁrst,  it  attenuates,  by  anesthetic  precondition-
ng,  the  ischemia-reperfusion  injury  due  to  CPB;18 and
econd,  it  reduces  pulmonary  vascular  resistance19
although  with  less  intensity  in  patients  without  pulmonary
ypertension).20
We  also  used  dexmedetomidine,  a  potent  2-
drenoceptor  agonist  (2-receptors  consist  of  three
ubtypes:  2a,  2b e  2c)  with  sympatholytic,  sedative,
mnesic  and  analgesic  properties.21 Its  selectivity  regarding
eceptors  1 and  2 compared  to  clonidine,  a  congener,  is
ight  times  higher.
In  2006,  But  et  al.,22 evaluating  the  effects  of
exmedetomidine  in  patients  with  pulmonary  hypertension
PH)  undergoing  cardiac  surgery,  concluded  that  dexmedeto-
idine,  in  addition  to  reducing  the  need  for  fentanyl,
ttenuated  the  increase  in  systemic  vascular  resistance
ndex  and  pulmonary  vascular  resistance.  It  reduced  the
ean  arterial  pressure,  mean  pulmonary  artery  pressure,
nd  pulmonary  wedge  capillary  pressure  compared  to
lacebo  group  values.
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In  our  case,  the  pressure  was  not  measured  in  the  more
istal  pulmonary  capillaries  as  in  the  patients  studied  by  the
uthors  cited  above.  The  mean  pulmonary  artery  pressure
increased)  could  only  be  studied  in  the  aneurysmal  area  by
oppler  echocardiographic  examination.
However,  even  without  being  able  to  tell  if  the  pressure
n  the  arterial  bed  distal  to  the  aneurysm  was  increased,
he  administration  of  a  drug  capable  of  reducing  the  adren-
rgic  response23 and  possibly  pulmonary  vasculature  blood
ressure22 allowed  the  inclusion  of  this  agent  in  the  anes-
hesia.
The  bolus  dose  of  dexmedetomidine  (1  g  kg−1)  is  pur-
osely  excluded.  It  is  assumed  that  due  to  the  effect  on  2b
eceptors  on  vascular  smooth  muscle,  the  bolus  loading  dose
esults  in  an  increase  in  blood  pressure 21,  which  would  be
ndesirable  in  patients  with  aneurysms.  Much  of  the  adverse
ffects  of  this  drug  occur  during  or  shortly  after  the  loading
ose  (bolus),21 so  we  opted  for  an  infusion  of  0.5  g  kg−1 h−1
or  15  min  and  then  reduce  it  to  0.4  g  kg−1 h−1.
Continuous  infusion  of  dexmedetomidine  was  maintained
ntil  the  ﬁrst  hours  of  the  patient  arrival  in  the  inten-
ive  care  unit  (ICU).  Thereby,  we  seek  to  extubate  the
atient  under  the  agent  safe  sedation  and  avoid  respiratory
epression21 and  increased  blood  pressure.
The  team  was  also  concerned  about  the  possibility  of
V  dysfunction  after  CPB.  The  right  ventricle  was  hyper-
rophic/dilated,  therefore,  more  susceptible  to  inadequate
rotection  by  cardioplegic  solution,  despite  all  care  about
he  volume  and  injection  time  of  cardioplegia.  It  was
nown  beforehand  that  the  time  of  aortic  clamping  dur-
ng  cardiopulmonary  bypass  (heart  ischemia)  would  be  from
oderate  to  prolonged,  due  to  the  size  of  the  surgery,  and
his  could  affect  the  myocardium.
To  avoid  a poor  performance  of  the  RV  at  the  end  of
PB,  dilate  the  pulmonary  vasculature,  and  reduce  pressure
n  the  surgical  sutures  (prosthesis  and  aneurysmorrhaphy),
e  opted  for  milrinone,  a  positive  inotropic  vasodilator  and
nhibitor  of  phosphodiesterase  III  (PDE  III).
Phosphodiesterase  III  is  an  enzyme  found  in  myocytes,
lood  vessels,24 sarcoplasmic  reticulum,  and  platelets.25 Mil-
inone  inhibits  PDE  III  and  reduces  the  hydrolysis  of  cyclic
MP  (with  less  effect  on  cyclic  GMP).
In  myocardium,  this  action  results  in  increased  intracel-
ular  ionized  calcium  and  heart  contractile  force  mediated
y  the  cyclic  AMP.
In  the  smooth  muscle  of  blood  vessels,  it  causes  a
ecrease  in  the  concentration  of  intracellular  calcium,
esulting  in  intense  vasodilation.26 The  vasodilator  action
f  milrinone  on  pulmonary  vasculature  independent  of  -
eceptors  and  may  even  exceed  the  action  of  -agents,
ncluding  isoproterenol,  he  most  potent  of  all.27
For  anesthesia  in  a  rare  case,  such  as  pulmonary  artery
runk  aneurysm,  our  choice  was  for  balanced  general  anes-
hesia  with  the  use  of  agents  known  to  allow  good  control  of
ystemic  and  pulmonary  vascular  resistance.  The  end  result,
ven  in  the  face  of  an  uncommon  disease,  was  satisfactory.
The  patient  was  extubated  in  the  ICU  2  h  after  the
urgery.  He  was,  therefore,  included  in  the  desirable  regime
f  fast-track28,29 (extubation  within  6--8  h  after  surgery).  ICU
ischarge  occurred  on  the  second  postoperative  day  and
ospital  discharged  a  week  after  the  procedure,  with  the
atient  without  any  complication  or  sequela.
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